BR112016023899A2 - composições compreendendo derivados de osteopontina para a inibição do crescimento do cabelo - Google Patents

composições compreendendo derivados de osteopontina para a inibição do crescimento do cabelo

Info

Publication number
BR112016023899A2
BR112016023899A2 BR112016023899A BR112016023899A BR112016023899A2 BR 112016023899 A2 BR112016023899 A2 BR 112016023899A2 BR 112016023899 A BR112016023899 A BR 112016023899A BR 112016023899 A BR112016023899 A BR 112016023899A BR 112016023899 A2 BR112016023899 A2 BR 112016023899A2
Authority
BR
Brazil
Prior art keywords
inhibiting hair
osteopontin
derivatives
compositions
hair growth
Prior art date
Application number
BR112016023899A
Other languages
English (en)
Inventor
Hultgårdh Nilsson Anna
Alenfall Jan
Dunér Pontus
Paus Ralf
Original Assignee
Follicum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Follicum Ab filed Critical Follicum Ab
Publication of BR112016023899A2 publication Critical patent/BR112016023899A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção fornece uma composição para inibir a produção de cabelo num mamífero compreendendo um componente de polipeptídeo ativo e um excipiente, transportador ou diluente farmaceuticamente aceitável e/ou cosmeticamente aceitável. a invenção proporciona ainda métodos para inibir a produção de cabelo num mamífero, por exemplo, humano.
BR112016023899A 2014-04-17 2015-04-17 composições compreendendo derivados de osteopontina para a inibição do crescimento do cabelo BR112016023899A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1406989.2A GB201406989D0 (en) 2014-04-17 2014-04-17 Novel treatments
PCT/GB2015/051165 WO2015159099A1 (en) 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth

Publications (1)

Publication Number Publication Date
BR112016023899A2 true BR112016023899A2 (pt) 2018-06-05

Family

ID=50928957

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016023899A BR112016023899A2 (pt) 2014-04-17 2015-04-17 composições compreendendo derivados de osteopontina para a inibição do crescimento do cabelo

Country Status (14)

Country Link
US (1) US20170143605A1 (pt)
EP (1) EP3131528A1 (pt)
JP (1) JP2017513856A (pt)
KR (1) KR20160136342A (pt)
CN (1) CN106413734A (pt)
AU (1) AU2015248652A1 (pt)
BR (1) BR112016023899A2 (pt)
CA (1) CA2945930A1 (pt)
GB (1) GB201406989D0 (pt)
IL (1) IL248084A0 (pt)
MX (1) MX2016013589A (pt)
RU (1) RU2016144971A (pt)
SG (1) SG11201608497YA (pt)
WO (1) WO2015159099A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3618845T3 (pl) * 2017-05-04 2021-08-02 Follicum Ab Peptydy do leczenia cukrzycy
KR102091567B1 (ko) * 2018-06-15 2020-03-20 인하대학교 산학협력단 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물
CA3116612A1 (en) * 2018-11-07 2020-05-14 Follicum Ab Peptide fragments for treatment of diabetes
WO2020161255A1 (en) * 2019-02-07 2020-08-13 Dsm Ip Assets B.V. Novel method for reducing hair growth
EP3692978A1 (en) * 2019-02-07 2020-08-12 DSM IP Assets B.V. Novel method
CA3136843A1 (en) * 2019-04-24 2020-10-29 Follicum Ab Topical formulation
CN115397458B (zh) 2020-02-25 2024-09-13 安普力菲卡控股集团公司 用于刺激毛发生长的组合物和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
EP1222913B1 (en) * 1999-10-21 2005-09-28 Kao Corporation Depilating method
EP1269196B1 (en) * 2000-03-23 2007-11-21 Glaxo Group Limited Method of screening for inhibitors of osteopontin
WO2008086449A2 (en) * 2007-01-09 2008-07-17 Oregon Health & Science University Synthetic osteopontin peptides and methods of use
GB2493540A (en) * 2011-08-10 2013-02-13 Follicum Ab Agents for stimulating hair growth in mammals

Also Published As

Publication number Publication date
US20170143605A1 (en) 2017-05-25
CN106413734A (zh) 2017-02-15
RU2016144971A (ru) 2018-05-17
AU2015248652A1 (en) 2016-10-20
CA2945930A1 (en) 2015-10-22
RU2016144971A3 (pt) 2018-11-30
SG11201608497YA (en) 2016-11-29
IL248084A0 (en) 2016-11-30
EP3131528A1 (en) 2017-02-22
GB201406989D0 (en) 2014-06-04
JP2017513856A (ja) 2017-06-01
WO2015159099A1 (en) 2015-10-22
MX2016013589A (es) 2017-07-04
KR20160136342A (ko) 2016-11-29

Similar Documents

Publication Publication Date Title
BR112016023899A2 (pt) composições compreendendo derivados de osteopontina para a inibição do crescimento do cabelo
CL2016003422A1 (es) Inhibidores de demetilasa-1 específico de lisina
EP3505620A4 (en) 2D ORGANOID FOR INFECTIONS AND GROWTH OF HUMAN DIARRHOEVIRUS AND USE OF THE TWO-DIMENSIONAL ORGANOID
WO2015061572A8 (en) Inhibitors of the fibroblast growth factor receptor
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
CL2016003423A1 (es) Inhibidores de demetilasa-1 específico de lisina
BR112018072467A2 (pt) composições farmacêuticas com permeação aumentada
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
WO2015038796A3 (en) Secretion of heme-containing polypeptides
AR100215A1 (es) Conjugados de anticuerpo-fármaco anti-ptk7
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
EP3491026A4 (en) HUMAN ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND METHODS
CL2015002897A1 (es) Inhibidores de bace1
WO2018013609A3 (en) Synthetic melanin nanoparticles uses thereof
WO2015104658A3 (en) Amorphous solid dispersion of dapagliflozin and process for the preparation of amorphous dapagliflozin
BR112018070497A2 (pt) métodos e formulações farmacêuticas para tratamento de condições oculares
WO2016007540A3 (en) Compositions and methods for treating dengue virus infection
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
MX2018005785A (es) Conjugados de anticuerpo anti-cd22-maytansina y metodos de uso de los mismos.
PH12017500602A1 (en) Methods for treating ocular conditions
WO2016172269A3 (en) Insulin analogs having shortened b chain peptides and associated methods
WO2016094374A8 (en) Compositions and methods for treatment of friedreich's ataxia
IN2013MU01985A (pt)
GEP20186879B (en) Cycloalkyl-linked diheterocycle derivatives

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements